The therapeutic approach with targeting liver proliferation is also supported by several reports showing that cell cycle proteins CDK4, Cyclin D3, E2F1, and liver cancer promoting protein Gankyrin play a critical role in development of NAFLD.19 The gene discussed is CDK4; the disease is liver cancer.